Figure 3
From: RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma
Clinical correlation analysis. (A) Kaplan–Meier survival curves of different levels of RGN expression obtained from TCGA, PrognoScan and GEPIA databases. (B) RGN expression was significantly correlated with clinical factors, including age, gender, tumor stage, T-stage and N-stage. (C) RGN expression was significantly downregulated after immunotherapy. (D) Univariate and multivariate Cox regression analyses showed that stage, age and RGN were independent predictors for poor survival in the TCGA-LUSC cohort.
